Literature DB >> 29808424

[Treatment with platelet aggregation inhibitors and additive proton pump inhibitors?]

W Fischbach1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29808424     DOI： 10.1007/s00108-018-0445-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  4 in total

1.  [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Authors:  W Fischbach; P Malfertheiner; P Lynen Jansen; W Bolten; J Bornschein; S Buderus; E Glocker; J C Hoffmann; S Koletzko; J Labenz; J Mayerle; S Miehlke; J Mössner; U Peitz; C Prinz; M Selgrad; S Suerbaum; M Venerito; M Vieth
Journal:  Z Gastroenterol       Date:  2016-04       Impact factor: 2.000

Review 2.  Complications of Proton Pump Inhibitor Therapy.

Authors:  Michael F Vaezi; Yu-Xiao Yang; Colin W Howden
Journal:  Gastroenterology       Date:  2017-05-19       Impact factor: 22.682

Review 3.  The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

Authors:  Daniel E Freedberg; Lawrence S Kim; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2017-03       Impact factor: 22.682

4.  Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.

Authors:  Linxin Li; Olivia C Geraghty; Ziyah Mehta; Peter M Rothwell
Journal:  Lancet       Date:  2017-06-13       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.